Ruth Roman
Instituto Oncologico Dr Rosell
Barcelona, CT, Spain
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.
Journal: Journal for immunotherapy of cancer
Published: July 08, 2026
Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 15, 2026
Expression of LIFR in tumor and SHOC2, YAP1 in plasma mRNA as potential biomarkers in KRAS G12C NSCLC.
Journal: Scientific reports
Published: February 19, 2026
Erratum: BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 24, 2025
BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 27, 2025
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors.
Journal: Molecular cancer
Published: February 27, 2023
Reference standards for gene fusion molecular assays on cytological samples: an international validation study.
Journal: Journal of clinical pathology
Published: July 17, 2021
RNA-Based Multiplexing Assay for Routine Testing of Fusion and Splicing Variants in Cytological Samples of NSCLC Patients.
Journal: Diagnostics (Basel, Switzerland)
Published: November 05, 2020
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer.
Journal: Molecular oncology
Published: September 09, 2020
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy.
Journal: Nature communications
Published: August 20, 2018
Cross-reactivity of EGFR mutation-specific immunohistochemistry assay in HER2-positive tumors.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: November 13, 2014
Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostatic specific antigen.
Journal: Actas urologicas espanolas
Published: April 25, 2013
Last Updated: 09/26/2026